Abbas Tafakhori

Safety and Efficacy of Nanocurcumin as Add-On Therapy to Riluzole in Patients With Amyotrophic Lateral Sclerosis: A Pilot Randomized Clinical Trial

Mona Ahmadi, Elmira Agah, Shahriar Nafissi et al. · Neurotherapeutics · 2018 · 137 citations · Full text

Nanomedicine, Amyotrophic Lateral Sclerosis, Therapeutic Nanomaterials +5

The synergistic effects of ω-3 fatty acids and nano-curcumin supplementation on tumor necrosis factor (TNF)-α gene expression and serum level in migraine patients

Mina Abdolahi, Abbas Tafakhori, Mansoureh Togha et al. · Immunogenetics · 2017 · 105 citations

Inflammation, Tumor Necrosis Factor, Anti-inflammatory +5

Efficacy and safety of oral ketamine versus diclofenac to alleviate mild to moderate depression in chronic pain patients: A double-blind, randomized, controlled trial

Morteza Jafarinia, Mohsen Afarideh, Abbas Tafakhori et al. · Journal of Affective Disorders · 2016 · 93 citations

Pain Therapy, Pain Research, Health Sciences +13

A Clinical and Molecular Genetic Study of 50 Families with Autosomal Recessive Parkinsonism Revealed Known and Novel Gene Mutations

Shaghayegh Taghavi, Rita Chaouni, Abbas Tafakhori et al. · Molecular Neurobiology · 2017 · 86 citations · Full text

Mendelian Disorder, Molecular Genetic Study, Genetic Disorder +10

Does oral administration of ketamine accelerate response to treatment in major depressive disorder? Results of a double-blind controlled trial

Somaye Arabzadeh, Elham Hakki-Kazazi, Nazila Shahmansouri et al. · Journal of Affective Disorders · 2018 · 86 citations

Ketamine Accelerate Response, Psychiatry, Does Oral Administration +11